Q32 Bio GAAP EPS of -$0.26 beats by $0.07 (QTTB:NASDAQ)
Q32 Bio reported Q3 GAAP EPS of -$0.26, beating estimates by $0.07. The company had $289.6M in cash and cash equivalents as of September 30, 2026, and stated it has sufficient funds for operations.

